Research ArticleArticle
Inhibition of PCSK6 May Play a Protective Role in the Development of Rheumatoid Arthritis
Feifei Wang, Lin Wang, Huiyu Jiang, Xiaotian Chang and Jihong Pan
The Journal of Rheumatology November 2014, jrheum.140435; DOI: https://doi.org/10.3899/jrheum.140435
Feifei Wang
From the Shandong Medicinal Biotechnology Centre; the Key Lab for Biotechnology Drugs of Ministry of Health; the Key Lab of Rare and Uncommon Disease; and the Shandong Qianfoshan Hospital, Jinan, China. Supported by the National Natural Science Foundation of China (81102275), the Natural Science Foundation of Shandong Province (ZR2011CQ028), the National Basic Research Program of China (2010CB529105), and Shandong Science and Technology Research Program (2012GSF12115). F. Wang, Masters student; L. Wang, PhD; H. Jiang, Masters student; J. Pan, PhD, Assistant Professor, Shandong Medicinal Biotechnology Centre, and the Key Lab for Biotechnology Drugs of Ministry of Health, and the Key Lab of Rare and Uncommon Disease, Shandong Province; X. Chang, Professor, Shandong Qianfoshan Hospital. Address correspondence to Dr. J. Pan, Shandong Medicinal Biotechnology Centre, Jingshi Road, Jinan, Shandong, China. E-mail: pjh933@sohu.com. Accepted for publication October 10, 2014.
Lin Wang
From the Shandong Medicinal Biotechnology Centre; the Key Lab for Biotechnology Drugs of Ministry of Health; the Key Lab of Rare and Uncommon Disease; and the Shandong Qianfoshan Hospital, Jinan, China. Supported by the National Natural Science Foundation of China (81102275), the Natural Science Foundation of Shandong Province (ZR2011CQ028), the National Basic Research Program of China (2010CB529105), and Shandong Science and Technology Research Program (2012GSF12115). F. Wang, Masters student; L. Wang, PhD; H. Jiang, Masters student; J. Pan, PhD, Assistant Professor, Shandong Medicinal Biotechnology Centre, and the Key Lab for Biotechnology Drugs of Ministry of Health, and the Key Lab of Rare and Uncommon Disease, Shandong Province; X. Chang, Professor, Shandong Qianfoshan Hospital. Address correspondence to Dr. J. Pan, Shandong Medicinal Biotechnology Centre, Jingshi Road, Jinan, Shandong, China. E-mail: pjh933@sohu.com. Accepted for publication October 10, 2014.
Huiyu Jiang
From the Shandong Medicinal Biotechnology Centre; the Key Lab for Biotechnology Drugs of Ministry of Health; the Key Lab of Rare and Uncommon Disease; and the Shandong Qianfoshan Hospital, Jinan, China. Supported by the National Natural Science Foundation of China (81102275), the Natural Science Foundation of Shandong Province (ZR2011CQ028), the National Basic Research Program of China (2010CB529105), and Shandong Science and Technology Research Program (2012GSF12115). F. Wang, Masters student; L. Wang, PhD; H. Jiang, Masters student; J. Pan, PhD, Assistant Professor, Shandong Medicinal Biotechnology Centre, and the Key Lab for Biotechnology Drugs of Ministry of Health, and the Key Lab of Rare and Uncommon Disease, Shandong Province; X. Chang, Professor, Shandong Qianfoshan Hospital. Address correspondence to Dr. J. Pan, Shandong Medicinal Biotechnology Centre, Jingshi Road, Jinan, Shandong, China. E-mail: pjh933@sohu.com. Accepted for publication October 10, 2014.
Xiaotian Chang
From the Shandong Medicinal Biotechnology Centre; the Key Lab for Biotechnology Drugs of Ministry of Health; the Key Lab of Rare and Uncommon Disease; and the Shandong Qianfoshan Hospital, Jinan, China. Supported by the National Natural Science Foundation of China (81102275), the Natural Science Foundation of Shandong Province (ZR2011CQ028), the National Basic Research Program of China (2010CB529105), and Shandong Science and Technology Research Program (2012GSF12115). F. Wang, Masters student; L. Wang, PhD; H. Jiang, Masters student; J. Pan, PhD, Assistant Professor, Shandong Medicinal Biotechnology Centre, and the Key Lab for Biotechnology Drugs of Ministry of Health, and the Key Lab of Rare and Uncommon Disease, Shandong Province; X. Chang, Professor, Shandong Qianfoshan Hospital. Address correspondence to Dr. J. Pan, Shandong Medicinal Biotechnology Centre, Jingshi Road, Jinan, Shandong, China. E-mail: pjh933@sohu.com. Accepted for publication October 10, 2014.
Jihong Pan
From the Shandong Medicinal Biotechnology Centre; the Key Lab for Biotechnology Drugs of Ministry of Health; the Key Lab of Rare and Uncommon Disease; and the Shandong Qianfoshan Hospital, Jinan, China. Supported by the National Natural Science Foundation of China (81102275), the Natural Science Foundation of Shandong Province (ZR2011CQ028), the National Basic Research Program of China (2010CB529105), and Shandong Science and Technology Research Program (2012GSF12115). F. Wang, Masters student; L. Wang, PhD; H. Jiang, Masters student; J. Pan, PhD, Assistant Professor, Shandong Medicinal Biotechnology Centre, and the Key Lab for Biotechnology Drugs of Ministry of Health, and the Key Lab of Rare and Uncommon Disease, Shandong Province; X. Chang, Professor, Shandong Qianfoshan Hospital. Address correspondence to Dr. J. Pan, Shandong Medicinal Biotechnology Centre, Jingshi Road, Jinan, Shandong, China. E-mail: pjh933@sohu.com. Accepted for publication October 10, 2014.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Inhibition of PCSK6 May Play a Protective Role in the Development of Rheumatoid Arthritis
Feifei Wang, Lin Wang, Huiyu Jiang, Xiaotian Chang, Jihong Pan
The Journal of Rheumatology Nov 2014, jrheum.140435; DOI: 10.3899/jrheum.140435